ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 42928367

The memory of the tumor microenvironment: epigenetic scarring and the hysteretic logic of therapeutic relapse.

Kokkanti RR and 4 others. Oncogene, 2026.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The memory of the tumor microenvironment: epigenetic scarring and the hysteretic logic of therapeutic relapse. Papers, record 42928367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42928367

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The memory of the tumor microenvironment: epigenetic scarring and the hysteretic logic of therapeutic relapse.
Journal
Oncogene
Year
2026
Publication types
Journal Article, Review
Revised in PubMed
2026-11-05

Source PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kokkanti RRRekha Ranihttps://orcid.org/0000-0001-6015-2629
2Biswas SSoumyajithttps://orcid.org/0009-0008-3012-7965
3Parida NNanditahttps://orcid.org/0009-0009-0078-6836
4Bajoria AAAtul Anandhttps://orcid.org/0000-0001-9796-9640
5Patnaik SSrinivashttps://orcid.org/0000-0003-2544-9229

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Tumor MicroenvironmentMajor topic
NeoplasmsMajor topic
Epigenesis, GeneticMajor topic
Neoplasm Recurrence, LocalMajor topic
Humans
Animals
Extracellular Matrix

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References133

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127,912,061Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade.Cell2016https://conductscience.org/library/papers/27912061PubMed
226,912,859Dynamics of epigenetic regulation at the single-cell level.Science2016https://conductscience.org/library/papers/26912859PubMed
319,931,152Matrix crosslinking forces tumor progression by enhancing integrin signaling.Cell2009https://conductscience.org/library/papers/19931152PubMed
416,397,526Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer.Nat Rev Cancer2006https://conductscience.org/library/papers/16397526PubMed
517,538,624Gene-specific control of inflammation by TLR-induced chromatin modifications.Nature2007https://conductscience.org/library/papers/17538624PubMed
623,999,443Targeting lactate metabolism for cancer therapeutics.J Clin Invest2013https://conductscience.org/library/papers/23999443PubMed
740,499,006Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm.Cancer Res2025https://conductscience.org/library/papers/40499006PubMed
817,957,189Models, mechanisms and clinical evidence for cancer dormancy.Nat Rev Cancer2007https://conductscience.org/library/papers/17957189PubMed
939,433,569Cancer treatment monitoring using cell-free DNA fragmentomes.Nat Commun2024https://conductscience.org/library/papers/39433569PubMed
1033,879,235Advances in epigenetic therapeutics with focus on solid tumors.Clin Epigenetics2021https://conductscience.org/library/papers/33879235PubMed

1 to 10 of 133

See all 133 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42928367

GET https://conductscience.org/api/papers/v1/42928367/references?page=2

API referenceFor AI assistants